Your browser doesn't support javascript.
loading
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA.
Aughton, Karen; Elander, Nils O; Evans, Anthony; Jackson, Richard; Campbell, Fiona; Costello, Eithne; Halloran, Christopher M; Mackey, John R; Scarfe, Andrew G; Valle, Juan W; Carter, Ross; Cunningham, David; Tebbutt, Niall C; Goldstein, David; Shannon, Jennifer; Glimelius, Bengt; Hackert, Thilo; Charnley, Richard M; Anthoney, Alan; Lerch, Markus M; Mayerle, Julia; Palmer, Daniel H; Büchler, Markus W; Ghaneh, Paula; Neoptolemos, John P; Greenhalf, William.
Afiliação
  • Aughton K; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK.
  • Elander NO; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK.
  • Evans A; Department of Oncology, Linköping University, SE-581 83 Linköping, Sweden.
  • Jackson R; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK.
  • Campbell F; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK.
  • Costello E; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK.
  • Halloran CM; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK.
  • Mackey JR; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK.
  • Scarfe AG; Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
  • Valle JW; Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
  • Carter R; The Christie NHS Foundation Trust, University of Manchester, Manchester M20 4BX, UK.
  • Cunningham D; Glasgow Royal Infirmary, Glasgow G4 0SF, UK.
  • Tebbutt NC; Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.
  • Goldstein D; Austin Health, Melbourne, VIC 3084, Australia.
  • Shannon J; Prince of Wales Hospital and Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
  • Glimelius B; Nepean Cancer Centre, University of Sydney, Sydney, NSW 2747, Australia.
  • Hackert T; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 05 Uppsala, Sweden.
  • Charnley RM; Department of Surgery, University of Heidelberg, 69047 Heidelberg, Germany.
  • Anthoney A; Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK.
  • Lerch MM; St James's University Hospital, Leeds LS9 7TF, UK.
  • Mayerle J; Department of Medicine A, University Medicine Greifswald, 17489 Greifswald, Germany.
  • Palmer DH; Department of Medicine A, University Medicine Greifswald, 17489 Greifswald, Germany.
  • Büchler MW; Medizinische Klinik und Poliklinik II, Klinikum der LMU München-Grosshadern, 81377 München, Germany.
  • Ghaneh P; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK.
  • Neoptolemos JP; Department of Surgery, University of Heidelberg, 69047 Heidelberg, Germany.
  • Greenhalf W; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK.
Cancers (Basel) ; 13(22)2021 Nov 17.
Article em En | MEDLINE | ID: mdl-34830914
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido